Conn. Attorney General Launches Anitrust Probe of Purdue
A day after a federal judge found that Purdue Pharma's patents protecting its OxyContin painkiller were invalid because the company deliberately misled the U.S. Patent and Trademark Office, Connecticut's Attorney General...To view the full article, register now.
Already a subscriber? Click here to view full article